Cargando…

Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update"

Detalles Bibliográficos
Autor principal:	Braun, Juergen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423486/ https://www.ncbi.nlm.nih.gov/pubmed/36737105 http://dx.doi.org/10.1136/ard-2023-223935

Ejemplares similares

Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
por: Michelsen, Brigitte, et al.
Publicado: (2023)

Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
por: Sepriano, Alexandre, et al.
Publicado: (2017)

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
por: Braun, J, et al.
Publicado: (2011)

Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
por: Regel, Andrea, et al.
Publicado: (2017)

Prediction of Treatment Response According to ASAS-EULAR Management Recommendations in 1 Year for Hip Involvement in Axial Spondyloarthritis Based on MRI and Clinical Indicators
por: Xie, Zhuoyao, et al.
Publicado: (2021)

Correction: Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
Publicado: (2017)

MRI in axial spondyloarthritis: understanding an ‘ASAS-positive MRI’ and the ASAS classification criteria
por: Diekhoff, Torsten, et al.
Publicado: (2022)

Predictors of Assessment of Spondyloarthritis International Society (ASAS) Health Index in Axial Spondyloarthritis and Comparison of ASAS Health Index between Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Data from the Catholic Axial Spondyloarthritis COhort (CASCO)
por: Min, Hong Ki, et al.
Publicado: (2019)

Etanercept in axial spondyloarthritis
por: Luo, Gui, et al.
Publicado: (2022)

Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists
por: Gossec, L, et al.
Publicado: (2008)

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis
por: Kiltz, Uta, et al.
Publicado: (2020)

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
por: van der Heijde, Désirée, et al.
Publicado: (2015)

Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis
por: Di Carlo, Marco, et al.
Publicado: (2016)

Non-Physical Disease Facets in Spondyloarthritis: An ASAS Health Index-Based Analysis between Psoriatic Arthritis and Axial Spondyloarthritis
por: Queiro, Rubén, et al.
Publicado: (2022)

Management of Axial Spondyloarthritis – Insights into Upadacitinib
por: Braun, Jürgen, et al.
Publicado: (2022)

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
por: Gossec, Laure, et al.
Publicado: (2020)

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
por: Smolen, Josef S, et al.
Publicado: (2018)

Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: results of the cross-sectional ASAS-COMOSPA study
por: Kishimoto, Mitsumasa, et al.
Publicado: (2021)

Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis
por: Wei, James Cheng‐Chung, et al.
Publicado: (2019)

Significance of structural changes in the axial skeleton in patients with axial spondyloarthritis: how important are lesions in the sacroiliac joint?
por: Braun, Juergen
Publicado: (2022)

Korean treatment recommendations for patients with axial spondyloarthritis
por: Seo, Mi Ryoung, et al.
Publicado: (2023)

Korean treatment recommendations for patients with axial spondyloarthritis
por: Seo, Mi Ryoung, et al.
Publicado: (2023)

Correction: EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Publicado: (2020)

The Reliability and Validity of a Korean Translation of the ASAS Health Index and Environmental Factors in Korean Patients with Axial Spondyloarthritis
por: Choi, Jung-Ho, et al.
Publicado: (2014)

Axial spondyloarthritis: synthetic magnetic resonance imaging in the detection of sacroiliac joint lesions
por: Zhang, Ke, et al.
Publicado: (2022)

Axial spondyloarthritis and psoriatic arthritis: mostly overlapping or substantially different diseases?
por: Braun, Juergen, et al.
Publicado: (2023)

Monkeypox Disease Outbreak (2022): Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Correction: Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
Publicado: (2018)

Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
por: Sun, Yuankai, et al.
Publicado: (2022)

Effects of exercise and physical activity promotion: meta-analysis informing the 2018 EULAR recommendations for physical activity in people with rheumatoid arthritis, spondyloarthritis and hip/knee osteoarthritis
por: Rausch Osthoff, Anne-Kathrin, et al.
Publicado: (2018)

Axial spondyloarthritis including ankylosing spondylitis
por: Braun, Jürgen
Publicado: (2018)

The value of the 2011 ASAS classification criteria in patients with Spondyloarthritis and the prognosis of non-radiographic axial Spondyloarthritis: data from a large cohort of a tertiary referral hospital
por: Kougkas, Nikolaos, et al.
Publicado: (2019)

Recent advances in managing axial spondyloarthritis
por: Agrawal, Priyanka, et al.
Publicado: (2020)

Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium”
por: Salaffi, Fausto, et al.
Publicado: (2022)

Monkeypox deaths in 2022 outbreak across the globe: correspondence
por: Sah, Ranjit, et al.
Publicado: (2023)

Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care
por: Poddubnyy, Denis, et al.
Publicado: (2018)

Enthesitis indices identify different patients with this characteristic in axial and peripheral spondyloarthritis and also in psoriatic arthritis: ASAS-PerSpA data
por: Granados, Raquel Ena María, et al.
Publicado: (2023)

Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts
por: Ez-Zaitouni, Zineb, et al.
Publicado: (2017)

Geographical prevalence of family history in patients with axial spondyloarthritis and its association with HLA-B27 in the ASAS-PerSpA study
por: Boel, Anne, et al.
Publicado: (2022)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
por: Smolen, Josef S, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3o6djnqre4k9q190tv6q96etno